vivo
imag
pet
spect
mri
vivo
fluoresc
microscopi
vivo
bioluminesc
anim
model
malaria
mainli
mice
made
larg
contribut
knowledg
hostpathogen
interact
immun
respons
drug
vaccin
design
nonhuman
primat
nhp
model
malaria
admittedli
underus
although
probabl
closer
model
mice
human
malaria
particular
nhp
model
allow
use
human
pathogen
plasmodium
falciparum
plasmodium
vivax
plasmodium
malaria
plasmodium
knowlesi
nhp
whether
natur
host
experiment
challeng
simian
plasmodium
also
serv
robust
preclin
model
simian
parasit
close
relat
human
counterpart
may
share
common
ancestor
display
similar
major
featur
human
infect
patholog
nhp
model
allow
longitudin
studi
earli
event
follow
sporozoit
inocul
later
event
includ
analysi
organ
tissu
particularli
liver
spleen
brain
bone
marrow
nhp
model
one
signific
advantag
mous
model
nhp
closest
rel
thu
biolog
similar
recent
develop
vivo
imag
tool
provid
insight
malaria
parasit
infect
diseas
mous
model
one
advantag
tool
limit
need
invas
procedur
tissu
biopsi
mani
technolog
avail
nhp
studi
provid
new
opportun
elucid
hostparasit
interact
aim
review
bring
malaria
commun
date
current
possibl
soon
term
vivo
imag
nhp
model
malaria
consid
pro
con
variou
techniqu
identifi
challeng
plethora
anim
model
avail
studi
plasmodium
biolog
pathogenesi
malaria
immun
vaccin
drug
efficaci
malaria
parasit
infect
wide
rang
anim
includ
reptil
bird
rodent
nhp
addit
human
four
speci
plasmodium
malaria
plasmodium
oval
plasmodium
falciparum
plasmodium
vivax
recogn
natur
malaria
parasit
human
recent
emerg
fifth
speci
plasmodium
knowlesi
morpholog
resembl
p
malaria
consequ
undoubtedli
misdiagnos
past
human
pathogen
main
simian
plasmodium
parasit
infect
old
world
primat
includ
p
knowlesi
plasmodium
coatneyi
plasmodium
fragil
plasmodium
cynomolgi
plasmodium
inui
plasmodium
fieldi
plasmodium
simioval
south
east
asia
well
plasmodium
gonderi
africa
simian
plasmodium
parasit
infect
new
world
primat
compris
plasmodium
brasilianum
plasmodium
simium
south
america
simian
plasmodium
parasit
share
similar
human
parasit
report
begin
xxth
centuri
deciph
evolutionari
histori
plasmodium
parasit
primat
host
restrict
matter
intens
research
determin
origin
human
plasmodium
parasit
emerg
plasmodium
parasit
show
larg
propens
jump
nhp
human
revers
origin
p
falciparum
recent
determin
african
ape
like
reservoir
speci
found
gorilla
bonobo
chimpanze
p
vivax
p
malaria
genet
close
relat
neotrop
p
simium
p
brasilianum
mechan
host
switch
new
world
primat
human
zoonosi
revers
anthroponosi
complet
unravel
new
world
monkey
suscept
human
p
falciparum
p
vivax
p
malaria
current
simian
plasmodium
speci
known
natur
infect
human
includ
p
knowlesi
also
although
rare
p
simium
south
america
p
cynomolgi
asia
close
related
human
nhp
host
human
simian
plasmodium
parasit
make
nhp
model
choic
human
malaria
biomed
research
commun
plethora
anim
model
avail
studi
plasmodium
biolog
pathogenesi
malaria
immun
vaccin
drug
efficaci
contrast
pathogen
hiv
infield
trial
experiment
human
challeng
feasibl
plasmodium
human
subject
mostli
use
assess
vaccineinduc
protect
nonetheless
anim
model
remain
highli
valuabl
avoid
ethic
problem
work
human
also
control
experiment
condit
inde
choic
pathogen
form
speci
strain
isol
clone
time
infect
allow
studi
differ
aspect
diseas
furthermor
type
infect
use
infect
red
blood
cell
irbc
sporozoit
lead
studi
specif
bloodstag
transmiss
liverstag
respect
anim
model
allow
longitudin
studi
earli
event
follow
sporozoit
inocul
analysi
clinicallysil
stage
collect
organ
tissu
confound
factor
previou
infect
coinfect
malnutrit
avoid
howev
singl
anim
model
perfectli
reproduc
spectrum
human
plasmodium
infect
malaria
immun
differ
parasitehost
combin
may
inde
view
asset
may
reflect
heterogen
human
malaria
highlight
recent
debat
anim
model
malaria
research
model
differ
strength
limit
degre
relev
thu
model
care
select
accord
scientif
issu
hypothes
address
mice
extens
use
model
malaria
human
plasmodium
parasit
unabl
infect
mice
rodent
malaria
parasit
may
use
four
wide
use
speci
plasmodium
berghei
plasmodium
yoelii
plasmodium
chabaudi
plasmodium
vinckei
use
inbr
outbr
mice
isol
natur
host
african
rat
p
berghei
adapt
laboratori
mice
rodent
plasmodium
infect
mice
display
main
featur
human
infect
diseas
complex
human
mous
model
develop
overcom
host
speci
barrier
use
p
falciparum
small
laboratori
anim
briefli
mice
reconstitut
human
hematopoiet
system
produc
human
rbc
suscept
sever
p
falciparum
strain
support
longlast
parasitemia
gametocyt
develop
would
ideal
studi
bloodstag
howev
perfect
model
avail
transient
model
report
involv
perfus
infect
rbc
immunodefici
mous
strain
transmiss
liverstag
studi
mice
engraft
human
hepatocyt
gener
evid
follow
infect
p
falciparum
sporozoit
liverstag
schizont
develop
complet
develop
liverstag
parasit
recent
report
liverstag
schizont
exhibit
exoerythrocyt
merozoit
format
merosom
releas
even
transit
p
falciparum
liverstag
infect
bloodstag
infect
gametocyt
develop
howev
main
drawback
human
mice
clearli
low
medium
throughput
also
inappropri
studi
p
vivax
requir
human
reticulocyt
thu
human
erythropoiesi
final
mous
model
adapt
assess
specif
immun
requir
matur
fulli
compet
human
immun
system
also
sever
wellestablish
nhp
model
avail
although
wide
use
probabl
nhp
studi
requir
appropri
specif
facil
possibl
associ
mosquito
facil
rigor
ethic
justif
anim
model
also
requir
close
collabor
work
primatologist
malariologist
special
train
personnel
safeti
issu
rais
anim
facil
requir
use
mosquitoborn
plasmodium
speci
infecti
human
human
plasmodium
parasit
macaqu
parasit
includ
p
cynomolgi
p
inui
nhp
studi
also
particularli
costli
nevertheless
mani
believ
model
worth
effort
commit
promot
use
nhp
model
malaria
close
reproduc
human
malaria
inde
continu
invest
nhp
system
recogn
prioriti
recent
meet
anim
model
research
sever
malaria
accord
molecular
timescal
vertebr
evolut
mice
human
separ
million
year
period
immun
system
subject
differ
select
pressur
diverg
hostpathogen
adapt
macaca
genu
close
relat
human
recent
common
ancestor
million
year
ago
phylogenet
proxim
human
nhp
associ
instanc
compar
dendrit
cell
subset
similar
panopli
pattern
recognit
receptor
central
studi
malaria
immunolog
vaccin
develop
vivo
malaria
liverstag
studi
human
virtual
imposs
wherea
nhp
provid
access
asymptomat
stage
includ
journey
sporozoit
skin
liver
dormant
hypnozoit
form
liver
seen
p
vivax
p
cynomolgi
addit
variou
gene
conserv
among
primat
parasit
p
falciparum
p
vivax
p
knowlesi
absent
rodent
parasit
p
berghei
p
yoelii
p
chabaudi
potenti
protect
efficaci
antigen
correspond
gene
new
genet
attenu
sporozoit
assess
mice
degre
attenu
result
delet
particular
gene
may
also
differ
plasmodium
speci
recent
wholegenom
sequenc
rhesu
macaqu
macaca
mulatta
cynomolgu
macaqu
macaca
fasciculari
make
speci
even
valuabl
model
human
diseas
also
spinoff
extens
use
nhp
speci
hivaid
research
numer
tool
detail
character
physiolog
immun
respons
character
genet
background
mhc
restrict
factor
kir
genet
avail
rhesu
cynomolgu
pigtail
macaqu
macaca
nemestrina
tetram
stain
quantifi
antigenspecif
cell
feasibl
sinc
mhc
class
type
possibl
drive
progress
well
illustr
primat
info
net
librari
inform
servic
gather
key
inform
variou
primat
speci
provid
link
resourc
nhp
biomed
research
http
pinprimatewisconsinedu
nonhuman
primat
reagent
resourc
whose
goal
facilit
use
nhp
produc
specif
reagent
antibodi
recombin
cytokin
share
inform
crossreact
immunolog
reagent
assay
http
nhpreagentsorg
similarli
new
research
center
dedic
preclin
research
program
hostpathogen
interact
human
vaccin
antimicrobi
treatment
nhp
recent
launch
franc
center
infecti
diseas
model
innov
therapi
idmit
http
idmitcenterfr
provid
scientif
commun
nhp
facil
cynomolgu
macaquesp
cynomolgi
model
current
implement
combin
recent
technolog
includ
imag
technolog
vivo
fluoresc
microscopi
mri
alreadi
avail
petct
optim
use
nhp
particular
emphasi
given
assay
standard
harmon
reagent
repositori
biobank
creat
sever
nhpparasit
combin
describ
various
use
studi
plasmodium
biolog
transmiss
immunolog
andor
patholog
acut
chronic
infect
sever
malaria
cerebr
malaria
placent
malaria
malariaassoci
patholog
liver
lung
kidney
spleen
involv
thrombocytopenia
hemorrhag
anemia
use
review
publish
recent
provid
summari
nhp
model
studi
hepat
infect
pathogenesi
variou
isol
strain
adapt
nhp
histori
characterist
eg
natur
vs
experiment
host
virul
lethal
capac
produc
infect
gametocyt
resist
antimalari
drug
complet
partial
develop
exhaust
list
elsewher
present
wide
use
model
vivo
model
human
malaria
use
human
parasit
host
specif
malaria
parasit
narrow
suitabl
nhp
speci
infect
p
falciparum
p
vivax
p
malaria
neotrop
primat
south
american
owl
monkey
aotu
spp
squirrel
monkey
saimiri
spp
furthermor
parasit
must
adapt
grow
nonnatur
host
p
oval
adapt
new
world
monkey
suscept
infect
sporozoit
andor
irbc
product
viabl
gametocyt
characterist
bloodstag
infect
requir
splenectomi
depend
hoststrain
combin
colombian
night
monkey
aotu
lemurinu
griseimembra
may
emerg
one
best
nhp
malaria
model
high
suscept
infect
blood
form
sporozoit
p
falciparum
p
vivax
saimiri
sciureu
use
investig
p
falciparum
bloodstag
human
parasit
splenectomi
requir
reproduc
high
parasitemia
inject
parasit
rbc
saimiri
boliviensi
consid
reliabl
model
p
vivax
chimpanze
also
suscept
p
falciparum
p
vivax
well
p
malaria
p
oval
howev
use
limit
ethic
reason
inde
european
union
ban
use
great
ape
research
purpos
chimpanze
bonobo
gorilla
orangutan
research
also
highli
restrict
us
obviou
advantag
new
world
primat
old
world
primat
model
human
malaria
human
parasit
use
howev
advantag
use
human
parasit
counterbalanc
limit
suppli
neotrop
primat
fewer
breed
coloni
macaqu
exampl
export
countri
origin
prohibit
recent
workshop
neotrop
primat
biomed
research
led
conclus
effort
pursu
develop
new
reagent
support
breed
coloni
includ
improv
coloni
veterinari
manag
final
less
blood
experiment
purpos
collect
speci
macaqu
p
knowlesi
primat
malaria
parasit
endem
south
east
asian
speci
exampl
cynomolgu
pigtail
macaqu
p
knowlesi
also
fifth
malaria
speci
natur
infect
human
caus
lifethreaten
diseas
experiment
infect
describ
wide
rang
nhp
old
world
primat
rhesu
macaqu
baboon
papio
spp
new
world
primat
squirrel
aotu
monkey
common
marmoset
callithrix
jacchu
interestingli
two
oppos
asexualblood
stage
outcom
rhesu
cynomolgu
macaqu
p
knowlesi
caus
sever
diseas
inevit
lethal
untreat
inocul
rhesu
macaqu
sporozoit
irbc
wherea
parasit
develop
control
chronic
infect
develop
natur
host
cynomolgu
macaqu
parasitemia
need
monitor
daili
p
knowlesi
asexu
life
cycl
h
parasit
increas
quickli
detriment
level
model
p
knowlesi
macaqu
mainli
use
investig
parasit
biolog
physiopatholog
immunolog
vaccin
studi
human
plasmodium
speci
p
knowlesi
infect
old
world
monkey
howev
mani
simian
plasmodium
speci
natur
infect
macaqu
use
experiment
model
human
malaria
p
coatneyi
p
fragil
natur
infect
cynomolgu
macaqu
bonnet
macaca
radiata
toqu
macaqu
macaca
sinica
respect
use
model
p
falciparum
variou
macaqu
mulatta
fasciculari
nemestrina
macaca
fuscata
sequestr
roset
sever
diseas
includ
cerebr
malaria
parasit
virul
sporozoit
inocul
rhesu
macaqu
japanes
macaqu
fuscata
p
cynomolgi
natur
infect
wide
varieti
macaqu
host
includ
cynomolgu
macaqu
model
studi
biolog
immunolog
patholog
p
vivax
mimic
biolog
pathogenesi
p
vivax
dormant
relaps
parasit
form
hypnozoit
similar
rbc
infect
featur
reticulocyt
although
p
fieldi
p
simioval
natur
infect
cynomolgu
pigtail
macaqu
toqu
macaqu
respect
share
characterist
p
oval
reproduc
better
featur
p
vivax
infect
use
model
p
vivax
rhesu
cynomolgu
macaqu
frequent
p
cynomolgi
p
inui
natur
infect
larg
varieti
macaqu
speci
consid
macaqu
model
p
malaria
display
persist
similar
kidney
patholog
macaqu
speci
natur
host
consequ
evolutionari
coadapt
note
also
anim
may
expos
malaria
experiment
infect
may
prefer
use
naiv
anim
captiveborn
area
preval
malaria
low
cynomolgu
macaqu
mauritiu
malaria
endem
region
pathogen
may
interfer
host
immun
respons
plasmodium
macaqu
also
use
studi
wide
rang
infect
human
pathogen
simian
counterpart
well
vaccin
thu
possibl
model
coinfect
macaqu
sivplasmodium
schistosomaplasmodium
studi
interfer
vaccineinduc
immun
respons
conclud
nhp
model
human
malaria
present
sever
advantag
mous
model
justifi
effort
facilit
improv
use
especi
true
vivo
imag
technolog
revolution
understand
malaria
last
year
use
mous
model
actual
limit
small
laboratori
anim
howev
insuffici
access
adequ
structur
equip
imag
nhp
associ
suitabl
confin
class
pathogen
larg
part
explain
rel
limit
explor
pathogen
transmiss
dissemin
use
vivo
imag
nhp
nevertheless
vivo
imag
entir
feasibl
larger
anim
monkey
even
though
adult
male
aotu
monkey
rhesu
macaqu
weigh
kg
averag
respect
cm
long
respect
mice
weigh
g
cm
long
earli
event
transmiss
dissemin
pathogen
host
organ
mucos
barrier
still
poorli
understood
case
better
character
earli
step
infect
need
develop
improv
prevent
strategi
therapi
vivo
imag
use
noninvas
longitudin
studi
allow
use
anim
minim
refin
molecular
imag
techniqu
optic
imag
fluoresc
bioluminesc
pet
positron
emiss
tomographi
spect
singlephoton
emiss
tomographi
document
molecular
cellular
event
method
also
complementari
differ
techniqu
appropri
differ
biolog
investig
differ
organ
strength
weak
variou
imag
techniqu
review
elsewher
fluoresc
imag
bioluminesc
imag
involv
detect
visibl
light
therefor
limit
studi
superfici
organ
mainli
use
small
anim
feasibl
use
bioluminesc
visual
infect
dissemin
variou
virus
murin
herp
viru
mous
hepat
viru
coronaviru
chikungunya
viru
demonstr
murin
model
rel
eas
use
rel
low
cost
imag
techniqu
make
use
explor
superfici
organ
even
larg
anim
furthermor
adapt
endoscop
intraop
techniqu
fluoresc
could
use
studi
deeper
organ
tradit
confoc
microscopi
imag
depth
intravit
multiphoton
imag
multiphoton
excit
extend
limit
maximum
mm
live
anim
huge
advantag
especi
excis
specimen
possibl
recent
twophoton
microscopi
use
imag
analyz
immun
respons
singl
cell
intact
tissu
timelaps
imag
live
tissu
inde
use
puls
infrar
laser
fluoresc
dye
excit
major
advanc
high
excit
wavelength
allow
deep
tissu
imag
rel
low
energi
constrain
focal
plane
limit
phototox
consequ
twophoton
microscopi
becom
techniqu
choic
follow
dynam
behavior
immun
cell
vivo
singl
cell
studi
murin
model
tumor
skin
graft
infect
instanc
intravit
twophoton
microscopi
poplit
lymph
node
mice
use
investig
fluoresc
label
inactiv
vesicular
stomat
viru
vsv
captur
lymph
transport
b
cell
compart
induc
humor
immun
also
use
investig
dynam
behavior
cell
infect
green
fluoresc
protein
gfp
express
hiv
stromal
environ
lymph
node
intravit
microscopi
skin
surgic
expos
intern
organ
offer
excel
resolut
studi
individu
cell
even
subcellular
structur
microorgan
although
strictli
noninvas
howev
techniqu
appli
murin
model
positron
emiss
tomographi
pet
magnet
reson
imag
mri
singl
photon
emiss
comput
tomographi
spect
also
use
small
larg
anim
inde
routin
use
clinic
purpos
techniqu
reveal
molecular
cellular
event
sensit
pet
high
rang
moll
independ
locat
depth
report
probe
combin
morphologicalanatom
molecular
imag
method
use
multimod
hardwar
andor
coregistr
postacquisit
process
allow
wholebodi
explor
earli
event
transmiss
pathogen
mucos
barrier
assess
dynam
pathogen
biodistribut
evalu
dynam
earli
event
follow
vaccin
determin
pharmacokinet
pharmacodynam
new
drug
infect
host
ct
comput
tomographi
mri
combin
pet
spect
provid
anatom
refer
mri
give
good
spatial
resolut
allow
anatom
imag
molecular
imag
associ
contrast
agent
cell
track
character
inflamm
cancer
cell
detect
locat
replic
pathogen
follow
pet
report
gene
imag
exampl
use
herp
simplex
thymidin
kinas
phosphoryl
broad
rang
nucleosid
analog
express
imag
sever
substrat
analog
includ
ffeau
acycloguanosin
deriv
hydroxymethyl
butyl
guanin
ffhbg
strategi
wide
use
variou
anim
model
includ
nhp
yet
malaria
context
pet
imag
also
use
detect
immun
activ
cell
lymphoid
organ
context
antitumor
immun
use
f
label
analog
mous
model
f
flt
human
antitumor
vaccin
pharmacokinet
biodistribut
metabol
toxic
diagnost
dose
novel
radiolabel
contrast
imag
agent
studi
nhp
facilit
translat
clinic
applic
vivo
brain
imag
pet
andor
mri
develop
divers
experiment
model
neurodegen
studi
instanc
imag
techniqu
includ
pet
directli
visual
concentr
local
amyloid
deposit
patholog
marker
alzheim
diseas
throughout
brain
immun
respons
viral
infect
shivinfect
macaqu
also
explor
spect
deliveri
botul
vaccin
studi
combin
pet
mri
also
f
fdg
petct
imag
also
use
assess
novel
combin
new
drug
nhp
model
tuberculosi
varieti
imag
technolog
avail
examin
live
materi
increas
rapidli
choic
imag
technolog
studi
base
biolog
issu
resolv
organ
tissu
explor
plasmodium
infect
malaria
studi
organ
tissu
interest
eg
skin
blood
lymph
liver
spleen
lung
brain
depend
malaria
stage
transmiss
liverand
bloodstag
similarli
form
pathogen
differ
parasit
develop
mosquito
inject
sporozoit
skin
sporozoit
character
size
length
diamet
mobil
characterist
migrat
skin
liver
includ
speed
glide
motil
cell
travers
product
invas
hepatocyt
parasit
develop
parasitophor
vacuol
egress
merosom
liver
cell
without
dormant
hypnozoit
format
depend
plasmodium
spp
merosom
burst
microvasculatur
merozoit
length
diamet
releas
invad
rbc
result
irbc
bind
noninfect
rbc
roset
adher
endotheli
cell
microvasculatur
sequestr
ruptur
schizontinfect
erythrocyt
releas
new
merozoit
parasit
eventu
differenti
male
femal
gametocyt
length
diamet
ingest
mosquito
therefor
strategi
vivo
imag
plasmodium
infect
malaria
thu
choic
imag
techniqu
adapt
resolut
depth
penetr
sensit
requir
multimod
imag
approach
entir
feasibl
vivo
imag
studi
malaria
mainli
focus
clinic
featur
diseas
use
variou
anim
model
includ
nhp
model
particular
featur
cerebr
malaria
nhp
explor
use
vivo
imag
cerebr
malaria
major
complic
sever
human
malaria
defin
acut
encephalopathi
caus
p
falciparum
infect
imag
analysi
brain
current
prefer
techniqu
evalu
diagnosi
impair
cerebr
function
numer
report
brain
imag
ct
mri
patient
cerebr
malaria
reveal
brain
swell
small
hemorrhag
lesion
focal
lesion
cerebrum
brainstem
howev
correl
patholog
chang
alter
metabol
activ
may
directli
reflect
neurolog
symptom
cerebr
malaria
patient
clearli
understood
mri
magnet
reson
spectroscopi
mr
use
studi
experiment
cerebr
malaria
identifi
earli
marker
mice
infect
p
berghei
anka
platelet
accumul
occur
microvasculatur
patient
cerebr
malaria
also
investig
mri
p
berghei
ankamurin
model
pet
imag
f
fdg
use
primat
model
sever
human
malaria
japanes
macaqu
infect
p
coatneyi
evalu
cerebr
glucos
metabol
valu
p
coatneyi
japanes
macaqu
model
studi
cerebr
malaria
demonstr
identif
cytoadher
infect
erythrocyt
brain
endotheli
cell
within
microvessel
vivo
similar
observ
human
cerebr
malaria
inde
fdgpet
imag
studi
demonstr
patholog
find
infect
monkey
similar
human
case
p
falciparum
malaria
group
studi
cerebr
glucos
metabol
japanes
macaqu
infect
p
coatneyi
also
investig
relationship
glucos
uptak
spleen
determin
fdgpet
histopatholog
chang
spleen
tissu
fdg
uptak
higher
infect
control
anim
may
reflect
activ
host
splenic
clearanc
system
glucos
consumpt
congest
malari
parasit
imag
analysi
progress
patholog
process
nhp
model
inform
mechan
malaria
use
vivo
imag
nhp
model
experiment
malaria
may
help
develop
imag
strategi
could
transfer
studi
human
howev
murin
model
malaria
particularli
concern
transmiss
liverstag
blood
stage
parasit
much
extens
use
nhp
model
vivo
imag
techniqu
vivo
imag
contribut
parasitolog
provid
dynam
imag
hostpathogen
interact
vivo
therebi
overcom
limit
postmortem
investig
vitro
studi
review
imag
studi
murin
model
malaria
use
fluoresc
includ
widefield
fluoresc
microscopi
intravit
microscopi
bioluminesc
analyz
migrat
parasit
transgen
parasit
express
gfp
red
fluoresc
protein
rfp
gfpluciferas
fusion
protein
use
fluoresc
p
berghei
sporozoit
use
studi
mosquito
mammalian
host
interact
dermi
malaria
parasit
vivo
microscopi
sporozoit
reach
liver
enter
lymph
vessel
accumul
drain
lymph
node
appear
resid
time
degrad
other
remain
skin
possibl
observ
count
number
fluoresc
parasit
eject
mosquito
time
reveal
limit
pool
plasmodium
sporozoit
avail
eject
within
vector
salivari
gland
rfpand
gfpexpress
parasit
variou
vivo
microscopi
techniqu
use
vivo
investig
behavior
p
berghei
parasit
hepat
tissu
murin
host
studi
provid
use
inform
primari
infect
process
parasit
interact
host
immun
cell
liver
use
bioluminesc
imag
describ
vitro
screen
inhibitor
chemic
antimalari
activ
blood
stage
p
berghei
vitro
vivo
assay
analyz
plasmodium
liver
stage
develop
use
transgen
p
berghei
pbgfpluccon
p
yoelii
pygfpluc
parasit
express
bioluminesc
report
protein
luciferas
assay
parasit
develop
hepatocyt
visual
quantifi
realtim
bioluminesc
imag
cultur
live
mice
luminesc
signal
measur
parasit
load
liver
parasit
pbgfpluccon
therefor
use
evalu
protect
immun
malaria
follow
immun
either
radiat
attenu
sporozoit
wildtyp
sporozoit
chloroquin
prophylaxi
transgen
parasit
straightforward
valuabl
tool
investig
biolog
immunolog
underli
mechan
pathogen
transmiss
dissemin
mechan
protect
malaria
howev
find
murin
model
requir
confirm
nhp
model
rodent
primat
differ
site
mechan
erythropoiesi
make
nhp
research
bloodstag
malaria
valuabl
furthermor
work
nhp
model
would
contribut
complet
understand
mechan
infect
parasit
p
vivax
speci
silent
liver
phase
human
could
explor
murin
model
sinc
rodent
parasit
dormant
liverstag
form
progress
variou
area
would
allow
use
nhp
model
human
malaria
extend
improv
techniqu
cultur
laboratori
mainten
plasmodium
complet
genom
sequenc
gener
transgen
strain
issu
specif
vivo
imag
field
advanc
area
line
research
agenda
malaria
erad
malera
recent
establish
consult
group
basic
scienc
enabl
technolog
current
possibl
cultur
plasmodium
throughout
complet
life
cycl
longterm
vitro
bloodstag
cultur
p
vivax
p
cynomolgi
possibl
contrast
p
falciparum
p
knowlesi
cultur
techniqu
avail
would
possibl
studi
least
bloodstag
parasit
easili
screen
drug
feed
femal
anophel
mosquito
without
use
infect
donor
nhp
continu
sourc
parasit
unfortun
vitroadapt
strain
lose
capac
produc
sexual
stage
like
p
knowlesi
bite
infect
mosquito
sporozoit
inject
use
experiment
sporozoit
inocul
sporozoit
isol
salivari
gland
mosquito
limit
ex
vivo
viabil
method
improv
preserv
would
use
mosquito
coloni
need
maintain
near
nhp
facil
facilit
transmiss
liverstag
studi
nhp
model
due
lack
effect
vitro
sporozoit
cultur
system
includ
transform
gametocyt
ookinet
sporogon
develop
sporozoit
occur
mosquito
whole
genom
sequenc
p
falciparum
p
vivax
p
knowlesi
report
draft
sequenc
three
p
cynomolgi
strain
publish
recent
improv
addit
genom
speci
progress
genet
manipul
gene
disrupt
mutat
tag
introduct
initi
develop
p
berghei
p
falciparum
gener
transgen
parasit
contain
imagingreport
gene
either
fluoresc
report
enzymat
report
luciferas
tk
essenti
vivo
imag
exogen
gene
introduc
either
plasmid
homolog
recombin
linear
dna
fragment
parasit
genom
target
silent
chromosom
locu
without
alter
phenotyp
parasit
disrupt
dispens
locu
p
falciparum
episom
plasmid
contain
origin
replic
deriv
bacteria
replic
plasmodium
equal
segreg
daughter
cell
mitosi
may
lost
stabl
episom
transfect
howev
possibl
differ
transient
episom
transfect
presenc
select
marker
transfect
dna
multipl
round
drug
treatment
allow
select
parasit
crossov
integr
episom
comprehens
review
detail
protocol
see
briefli
asexu
stage
haploid
genom
thu
prefer
stage
gener
transgen
parasit
requir
modif
singl
allel
optim
condit
defin
electropor
nucleofect
ensur
access
exogen
dna
parasit
nucleu
preserv
viabil
transfect
effici
differ
accord
development
stage
parasit
plasmodium
speci
infect
erythrocyt
contain
ringstag
parasit
p
falciparum
matur
schizont
p
berghei
use
genet
manipul
transfect
eg
resist
fluoresc
parasit
select
clone
either
vivo
vitro
variou
promot
homolog
heterolog
differ
strength
time
activ
eg
stagespecif
condit
constitut
avail
use
speci
third
plasmodium
parasit
transfect
report
p
knowlesi
stabl
transfect
p
vivax
yet
describ
transient
transfect
p
vivax
bloodstag
parasit
use
p
vivaxinfect
reticulocyt
splenectom
monkey
report
stabl
transfect
p
cynomolgi
demonstr
standard
gener
report
genet
modifi
primat
malaria
parasit
contrast
rodent
transgen
parasit
sever
transgen
p
falciparum
express
imag
report
gene
bloodstag
use
vitro
assay
tabl
sever
malaria
nhp
model
develop
studi
hostpathogen
interact
diseas
pathogenesi
malaria
immun
drug
vaccin
new
world
primat
aotu
saimiri
use
experiment
infect
either
human
malaria
speci
except
p
oval
simian
malaria
speci
anim
model
avail
studi
vaccin
efficaci
drug
suscept
human
malaria
parasit
p
falciparum
p
vivax
macaqu
old
world
primat
infect
simian
malaria
parasit
also
use
studi
biolog
human
malaria
explor
mechan
treatment
sever
patholog
associ
malaria
infect
main
model
list
transgen
p
falciparum
bloodstag
express
transgen
gfpmcherri
p
cynomolgi
constitut
express
fluoresc
transgen
gfp
p
knowlesi
bloodstag
express
fluoresc
imag
host
imag
techniqu
like
lack
gametocyt
product
theoret
rbc
infect
transgen
parasit
could
use
vivo
imag
bloodstag
transgen
p
falciparum
express
imag
report
gene
throughout
entir
parasit
life
cycl
includ
p
falciparum
express
gfp
deposit
malaria
research
refer
reagent
resourc
center
test
liverstag
use
ex
vivo
human
primari
hepatocyt
infect
p
falciparum
express
luciferasegfp
fusion
test
liverstag
use
human
liver
chimer
mice
avail
vivo
imag
studi
nhp
model
malaria
recent
transgen
p
cynomolgi
two
express
cassett
constitut
express
gfp
mcherri
develop
ex
vivo
infect
primari
hepatocyt
rhesu
monkey
perform
develop
liver
stage
hypnozoit
form
document
live
fluoresc
microscopi
final
adapt
p
knowlesi
line
express
gfp
throughout
asexu
bloodstag
cycl
continu
cultur
human
erythrocyt
recent
demonstr
provid
potenti
tool
studi
bloodstag
nhp
vivo
imag
enorm
power
approach
deciph
hostplasmodium
interact
mous
model
nhp
model
extrem
valuabl
model
human
malaria
consequ
unsurpris
vivo
imag
increasingli
link
primat
parasitolog
particularli
becom
clear
vivo
imag
feasibl
larger
anim
howev
far
studi
use
vivo
imag
approach
nhp
rare
limit
pet
imag
document
inflamm
cerebr
malaria
fuscatap
coatneyi
model
admittedli
facil
dual
nhpmalaria
expertis
avail
desir
model
upandrun
appropri
vivo
imag
devic
difficult
find
tabl
nevertheless
list
transgen
parasit
encod
imag
report
gene
usabl
nhp
model
grow
tabl
knowledg
yet
test
vivo
doubt
complex
interact
pathogen
host
immun
system
properli
understood
studi
nativ
tissu
environ
inde
vivo
dynam
imag
techniqu
reveal
differ
vitro
data
cellmedi
elimin
malaria
liver
stage
develop
new
imag
tool
applic
nhp
model
allow
better
understand
biolog
plasmodium
host
immun
respons
parasit
parasit
cell
well
develop
novel
therapeut
strategi
conclud
vivo
imag
nhp
model
malaria
could
help
explor
follow
top
four
topic
studi
earli
event
transmiss
character
dynam
skin
stage
liver
infect
longitudin
character
hypnozoit
form
infect
relaps
timelaps
imag
invas
red
blood
cell
dynam
imag
hostparasit
interact
immun
